Article

Rapid <i>in vitro</i> assays for screening neutralizing antibodies and antivirals against SARS-CoV-2

2020-07-23

Abstract excerpt

Towards the end of 2019, a novel coronavirus (CoV) named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), genetically similar to severe acute respiratory syndrome coronavirus-1 (SARS-CoV-1), emerged in Wuhan, Hubei province of China, and has been responsible of coronavirus disease 2019 (COVID-19) in humans. Since its first report, SARS-CoV-2 has resulted in a global pandemic, with over 10 million huma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b3b97cfd-be09-5746-b806-36352ce19eb1
DOI: 10.1101/2020.07.22.216648

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Rapid <i>in vitro</i> assays for screening neutralizing antibodies and antivirals against SARS-CoV-2DOI 10.1101/2020.07.22.216648Read

Development of a SARS-CoV-2 monoclonal antibody panel and its applicability as a reagent in high-throughput fluorescence reduction neutralization and immunohistochemistry assaysSemantic proximity Read

A novel in-cell ELISA assay allows rapid and automated quantification of SARS-CoV-2 to analyse neutralizing antibodies and antiviral compoundsSemantic proximity Read

A rapid and efficient screening system for neutralizing antibodies and its application for the discovery of potent neutralizing antibodies to SARS-CoV-2 S-RBDSemantic proximity Read

Scalable, Micro-Neutralization Assay for Qualitative Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical SamplesSemantic proximity Read

Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particlesSemantic proximity Read

Development of Potent and Effective Synthetic SARS-CoV-2 Neutralizing NanobodiesSemantic proximity Read

A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19Semantic proximity Read

A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell CultureSemantic proximity Read

A SARS-CoV-2 nucleocapsid protein TR-FRET assay amenable to high-throughput screeningSemantic proximity Read

A Safe Pseudotyped Lentivirus-Based Assay to Titer SARS-CoV-2 Neutralizing AntibodiesSemantic proximity Read

A rapid cell-free expression and screening platform for antibody discoverySemantic proximity Read

Identification of SARS-CoV-2-against aptamer with high neutralization activity by blocking the RBD domain of spike protein 1Semantic proximity Read